Market Cap: $97.53B
Market Cap: $97.53B
Open
$53.74
Prev. Close
$49.24
High
$53.75
Low
$52.44
GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets.
GSK plc trades on the New York Stock Exchange under the ticker GSK, priced in USD.
GSK plc has a market capitalisation of $97.53B, based on its latest share price.
GSK trades at 17.47 times its trailing 12-month earnings.
Over the past 52 weeks GSK has traded between $45.81 and $61.70.
Yes. GSK plc's dividend yields 3.60% at the current share price, paying out 62% of its earnings.
Profitable, with a net margin of 13.0% over the last 12 months.
The analyst consensus rating for GSK is Hold. Analysts' average 12-month price target of $57.95 implies 19% upside.
Luke Victor Miels is the CEO of GSK plc, which is headquartered in London.
Generated automatically from reported financial data. General information only, not financial advice.

GSK plc ( GSK ) stands at a crucial juncture as it navigates the complex landscape of biopharmaceuticals, aiming to secure and enhance its market position amidst impending patent expirations and an ev…

GSK Plc (Ticker: GSK) makes significant strides in addressing unmet medical needs for patients with pyelonephritis, a challenging kidney infection. The focus on innovative treatment pathways underscor…

On June 10, 2026, GSK Plc (Ticker: GSK) announces its strategic acquisition of Nuvalent, Inc., a clinical-stage precision oncology firm, for $10.6 billion. This acquisition exemplifies GSK's commitmen…
U.S. Government’s Vaccine Advisory Panel Actions Under Legal Scrutiny A federal court's recent commentary on the U.S. government's handling of vaccine recommendations signals a significant development…